About Aurobindo Pharma
Aurobindo Pharma is a company based in Hyderabad (India) founded in 1986 by P V Ramprasad Reddy and K Nityananda Reddy.. The company has 40,750 employees as of March 31, 2024. Aurobindo Pharma has completed 8 acquisitions, including Advent Pharma, GLS Pharma and Generis Farmaceutica. Aurobindo Pharma offers products and services including APIs, Biosimilars, and Speciality Products. Aurobindo Pharma operates in a competitive market with competitors including Almac Group, Indoco Remedies, Concord Biotech, BDR Pharmaceuticals Internationals and Asymchem, among others.
- Headquarter Hyderabad, India
- Employees 40750 as on 31 Mar, 2024
- Founders P V Ramprasad Reddy, K Nityananda Reddy
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Aurobindo Pharma Ltd
-
Annual Revenue
$3.67 B (USD)9.32as on Mar 31, 2024
-
Net Profit
$407.24 M (USD)9.86as on Mar 31, 2024
-
EBITDA
$753.39 M (USD)12.89as on Mar 31, 2024
-
Latest Funding Round
-
Investors
Gates Foundation
& 1 more
-
Employee Count
40750
as on Mar 31, 2024
-
Investments & Acquisitions
Advent Pharma
& 7 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Aurobindo Pharma
Aurobindo Pharma is a publicly listed company on the NSE with ticker symbol AUROPHARMA in India, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Aurobindo Pharma
Aurobindo Pharma offers a comprehensive portfolio of products and services, including APIs, Biosimilars, and Speciality Products. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Raw materials used in drug manufacturing for global markets.
Generic biologics targeting oncology and immunology therapies.
Advanced drugs for specific therapeutic needs worldwide.
Unlock access to complete
Unlock access to complete
Funding Insights of Aurobindo Pharma
- Total Funding Total Funding
- Total Rounds 3
- Last Round Last Round
-
First Round
First Round
(11 Sep 1999)
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2017 | Amount | Post-IPO - Aurobindo Pharma | Valuation |
investors |
|
| Apr, 2011 | Amount | Post-IPO - Aurobindo Pharma | Valuation |
investors |
|
| Sep, 1999 | Amount | Post-IPO - Aurobindo Pharma | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Aurobindo Pharma
Aurobindo Pharma has secured backing from 2 investors, including institutional and venture fund investors. Prominent investors backing the company include Gates Foundation and Templeton Private Equity Partners. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Global private equity investments are managed by the firm.
|
Founded Year | Domain | Location | |
|
Charitable foundation investments on poverty reduction and healthcare
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Aurobindo Pharma
Aurobindo Pharma has strategically engaged in corporate development activities, having acquired 8 companies. Notable acquisitions include Advent Pharma, GLS Pharma and Generis Farmaceutica. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bio-conjugate technologies for bacterial vaccines and conjugates are developed.
|
2008 | ||||
|
Generic liquid and solid formulations are manufactured for pharmaceuticals.
|
2005 | ||||
|
Oncology APIs and anti-cancer products are manufactured.
|
2004 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Aurobindo Pharma
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Aurobindo Pharma Comparisons
Competitors of Aurobindo Pharma
Aurobindo Pharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Almac Group, Indoco Remedies, Concord Biotech, BDR Pharmaceuticals Internationals and Asymchem, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Integrated CDMO services for biopharma R&D and manufacturing are offered.
|
|
| domain | founded_year | HQ Location |
APIs manufacturing and formulation services are provided in therapeutic segments.
|
|
| domain | founded_year | HQ Location |
APIs and enzymes are manufactured through fermentation by the CDMO.
|
|
| domain | founded_year | HQ Location |
APIs and finished products are developed and manufactured.
|
|
| domain | founded_year | HQ Location |
APIs and peptides are developed and manufactured by Asymchem.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Aurobindo Pharma
Frequently Asked Questions about Aurobindo Pharma
When was Aurobindo Pharma founded?
Aurobindo Pharma was founded in 1986 and raised its 1st funding round 13 years after it was founded.
Where is Aurobindo Pharma located?
Aurobindo Pharma is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.
Who is the current CEO of Aurobindo Pharma?
Sanjay Chaturvedi is the current CEO of Aurobindo Pharma.
How many employees does Aurobindo Pharma have?
As of Mar 31, 2024, the latest employee count at Aurobindo Pharma is 40,750.
What is the annual revenue of Aurobindo Pharma?
Annual revenue of Aurobindo Pharma is $3.67B as on Mar 31, 2024.
What does Aurobindo Pharma do?
Aurobindo Pharma was founded in 1986 in Hyderabad, India, and operates within the pharmaceutical sector. Generic drugs and biocatalytic solutions are developed and manufactured by the company, with a focus on active pharmaceutical ingredients and formulations. Operations are conducted globally, serving markets in over 150 countries through exports and partnerships. Leadership is provided by co-founders P V Ramprasad Reddy and K Nityananda Reddy, alongside CEO Sanjay Chaturvedi.
Who are the top competitors of Aurobindo Pharma?
Aurobindo Pharma's top competitors include Concord Biotech, BDR Pharmaceuticals Internationals and Almac Group.
What products or services does Aurobindo Pharma offer?
Aurobindo Pharma offers APIs, Biosimilars, and Speciality Products.
Is Aurobindo Pharma publicly traded?
Yes, Aurobindo Pharma is publicly traded on NSE under the ticker symbol AUROPHARMA.
How many acquisitions has Aurobindo Pharma made?
Aurobindo Pharma has made 8 acquisitions, including Advent Pharma, GLS Pharma, and Generis Farmaceutica.
Who are Aurobindo Pharma's investors?
Aurobindo Pharma has 2 investors. Key investors include Gates Foundation, and Templeton Private Equity Partners.
What is Aurobindo Pharma's ticker symbol?
The ticker symbol of Aurobindo Pharma is AUROPHARMA on NSE.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.